Care During Chemotherapy and Beyond
Trade names: Idamycin®, Idamycin
Chemocare.com uses generic names in all descriptions of drugs. Idamycin is the trade
name for idarubicin. idamycin PFS is another name for idarubicin. In some cases,
health care professionals may use the trade name idamycin or other names idamycin
PFS when referring to the generic drug name idarubicin.
Drug type: Idarubicin is an anti-cancer ("antineoplastic"
or "cytotoxic") chemotherapy drug. This medication is classified as an "anthracyline
antitumor antibiotic." (For more detail, see "How this drug works" section
What Idarubicin Is Used For:
- Acute myelogenous leukemia
- Acute lymphoblastic leukemia
- Chronic myelogenous leukemia (in blast crisis)
- Myelodysplastic syndromes
Note: If a drug has been approved for one use, physicians
may elect to use this same drug for other problems if they believe it may be helpful.
How Idarubicin Is Given:
- Idarubicin is given by intravenous injection (IV). The syringe needle is placed
directly into the tubing of a freely flowing IV solution into a vein or central
line and the drug is given over several minutes.
- Idarubicin is a vesicant. A vesicant is a chemical that causes extensive tissue
damage and blistering if it escapes from the vein. The nurse or doctor who
gives this drug must be carefully trained. If you notice redness or swelling
at the IV site while you are receiving idarubicin, alert your health care professional
- The amount of idarubicin that you will receive depends on many factors, including
your height and weight, your general health or other health problems, and the type
of cancer or condition being treated. Your doctor will determine your dose
Important things to remember about the side effects of idarubicin:
- Most people do not experience all of the side effects listed.
- Side effects are often predictable in terms of their onset and duration.
- Side effects are almost always reversible and will go away after treatment is complete.
- There are many options to help minimize or prevent side effects.
- There is no relationship between the presence or severity of side effects and the
effectiveness of the medication.
The following side effects are common (occurring in greater than 30%) for
patients taking idarubicin:
- Pain along the site where the medication was given.
- Low blood counts. Your white and red blood cells and platelets may temporarily
decrease. This can put you at increased risk for infection, anemia and/or
Nadir: Meaning low point, nadir is the point in time between chemotherapy
cycles in which you experience low blood counts.
Onset: none noted
Nadir: 10-15 days
Recovery: 21 days
- Urine may appear red, red-brown, orange or pink from the color of the medication
for one to two days after you receive a dose.
- Nausea or vomiting (usually mild, occurs within 1-2 hours of treatment).
- Mouth sores (in the first week after therapy).
- Hair loss on the scalp or elsewhere on the body (called alopecia). Most patients
do lose some or all of their hair during their treatment. But your hair will
grow back after treatment is completed.
- Diarrhea/abdominal cramps.
These side effects are less common side effects (occurring in about 10-29%)
of patients receiving idarubicin:
- Nail thickening, nail banding (see skin reactions)
- Discoloration of the skin or nails (see skin reactions)
- Darkening of the skin where previous radiation treatment has been given (radiation
recall - see skin reactions).
- Hand -foot syndrome (Palmar-plantar erythrodysesthesia or PPE) -skin rash, swelling,
redness, pain and/or peeling of the skin on the palms of hands and soles of feet.
- Loss of fertility. Meaning, your ability to conceive or father a child may
be affected by idarubicin. Discuss this issue with your health care provider.
- Heart rhythm abnormalities, generally without symptoms and short lived.
- Increases in blood tests measuring liver function. These return to normal
once treatment is discontinued (see liver problems).
A serious but uncommon side effect of idarubicin can be interference with
the pumping action of the heart. You can receive only up to a certain amount
of idarubicin during your lifetime. This "lifetime maximum dose" may be lower
if you have heart disease risk factors such as radiation to the chest, advancing
age, and use of other heart-toxic drugs. Your doctor will check your heart
function before you may take any idarubicin and will monitor your heart closely
during your treatment. Dose-related heart problems can occur as late as 7
or 8 years after treatments have ended.
Not all side effects are listed above. Some that are rare (occurring in less than
10% of patients) are not listed here. However, you should always inform your
health care provider if you experience any unusual symptoms.
When to contact your doctor or health care provider:
Contact your health care provider immediately, day or night, if you should
experience any of the following symptoms:
- Fever of 100.4 F (38 C) or higher, chills (possible signs of infection)
- Blistering at the IV site
- Shortness of breath, wheezing, difficulty breathing, closing up of the throat, swelling
of facial features, hives (possible allergic reaction).
The following symptoms require medical attention, but are not an emergency.
Contact your health care provider within 24 hours of noticing any of the
- Nausea (interferes with ability to eat and unrelieved with prescribed medication)
- Vomiting (vomiting more than 4-5 times in a 24 hour period)
- Mouth sores (painful redness, swelling or ulcers)
- Diarrhea (4-6 episodes in a 24-hour period)
- Fast or irregular heart beats
- Unusual bleeding or bruising
- Black or tarry stools, or blood in your stools or urine
- Extreme fatigue (unable to carry on self-care activities)
- Swelling of the feet or ankles
- Redness, itchiness or pus in eyes
Always inform your health care provider if you experience any unusual symptoms.
- Before starting idarubicin treatment, make sure you tell your doctor about any other
medications you are taking (including prescription, over-the-counter, vitamins,
herbal remedies, etc.). Do not take aspirin, or products containing
aspirin unless your doctor specifically permits this.
- Do not receive any kind of immunization or vaccination without your doctor's approval
while taking idarubicin.
- Inform your health care professional if you are pregnant or may be pregnant prior
to starting this treatment. Pregnancy category D (idarubicin may be hazardous to
the fetus. Women who are pregnant or become pregnant must be advised of the
potential hazard to the fetus).
- For both men and women: Do not conceive a child (get pregnant) while taking idarubicin.
Barrier methods of contraception, such as condoms, are recommended. Discuss with
your doctor when you may safely become pregnant or conceive a child after therapy.
- Do not breast feed while taking this medication.
- You may be more sensitive to sunlight, take extra care to avoid sun exposure.
- People with congestive heart failure, those who have already had high doses of this
drug or a similar drug, and those with permanent problems with blood counts (bone
marrow suppression) cannot receive this drug.
- Apply ice if you have any pain, redness or swelling at the IV site, and notify your
- You may be at risk of infection so try to avoid crowds or people with colds, and
report fever or any other signs of infection immediately to your health care provider.
- Wash your hands often.
- To reduce nausea, take anti-nausea medications as prescribed by your doctor, and
eat small, frequent meals.
- To help treat/prevent mouth sores, use a soft toothbrush, and rinse three times
a day with 1/2 to 1 teaspoon of baking soda and/or 1/2 to 1 teaspoon of salt mixed
with 8 ounces of water.
- Use an electric razor and a soft toothbrush to minimize bleeding.
- Avoid contact sports or activities that could cause injury.
- Avoid sun exposure. Wear SPF 15 (or higher) sunblock and protective clothing.
- Drink two to three quarts of fluid every 24 hours, unless you are instructed otherwise.
- Get plenty of rest.
- Maintain good nutrition.
- In general, drinking alcoholic beverages should be minimized or avoided. You
should discuss this with your doctor.
- If you experience symptoms or side effects, be sure to discuss them with your health
care team. They can prescribe medications and/or offer other suggestions that
are effective in managing such problems.
Monitoring and Testing:
A baseline heart evaluation is recommended before starting treatment, and a heart
function test will be done as your doctor prescribes. You will be checked
regularly by your doctor while you are taking idarubicin, to monitor side effects
and check your response to therapy. Periodic blood work to monitor your complete
blood count (CBC) as well as the function of other organs (such as your kidneys
and liver) will also be ordered by your doctor.
How Idarubicin Works:
Cancerous tumors are characterized by cell division, which is no longer controlled
as it is in normal tissue. "Normal" cells stop dividing when they come
into contact with like cells, a mechanism known as contact inhibition. Cancerous
cells lose this ability. Cancer cells no longer have the normal checks and
balances in place that control and limit cell division. The process of cell
division, whether normal or cancerous cells, is through the cell cycle. The
cell cycle goes from the resting phase, through active growing phases, and then
to mitosis (division).
The ability of chemotherapy to kill cancer cells depends on its ability to halt
cell division. Usually, the drugs work by damaging the RNA or DNA that tells
the cell how to copy itself in division. If the cells are unable to divide,
they die. The faster the cells are dividing, the more likely it is that chemotherapy
will kill the cells, causing the tumor to shrink. They also induce cell suicide
(self-death or apoptosis).
Chemotherapy drugs that affect cells only when they are dividing are called cell-cycle
specific. Chemotherapy drugs that affect cells when they are at rest are called
cell-cycle non-specific. The scheduling of chemotherapy is set based on the
type of cells, rate at which they divide, and the time at which a given drug is
likely to be effective. This is why chemotherapy is typically given in cycles.
Chemotherapy is most effective at killing cells that are rapidly dividing.
Unfortunately, chemotherapy does not know the difference between the cancerous cells
and the normal cells. The "normal" cells will grow back and be healthy but in the
meantime, side effects occur. The "normal" cells most commonly affected by
chemotherapy are the blood cells, the cells in the mouth, stomach and bowel, and
the hair follicles; resulting in low blood counts, mouth sores, nausea, diarrhea,
and/or hair loss. Different drugs may affect different parts of the body.
Idarubicin is classified as an antitumor antibiotic. Antitumor antibiotics
are made from natural products produced by species of the soil fungus Streptomyces.
These drugs act during multiple phases of the cell cycle and are considered cell-cycle
specific. Idarubicin belongs to the anthracycline category of antitumor antibiotics.
Note: We strongly encourage you to talk with your health
care professional about your specific medical condition and treatments. The information
contained in this website is meant to be helpful and educational, but is not a substitute
for medical advice.
Chemocare.com is designed to provide the latest information about chemotherapy to patients and their families, caregivers and friends. For information about the 4th Angel Mentoring Program visit www.4thangel.org